|
|
See Category: Neoplasms
See Header: Malignant melanoma of other and unspecified parts of face
ICD-10 (CM) Code and Descriptor
|
C43.30 |
Malignant melanoma of unspecified part of face
|
C4330 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 49.67%
|
25.20%
|
8.70%
|
4.84%
|
3.28%
|
2.34%
|
1.71%
|
1.10%
|
0.68%
|
0.49%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C43.30*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,876
|
1,881
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,122
|
1,122
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,108
|
1,108
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
951
|
953
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
510
|
510
|
|
84443
|
ASSAY THYROID STIM HORMONE |
472
|
472
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
298
|
29,921
|
|
G1004
|
CDSM NDSC |
283
|
384
|
|
71260
|
CT THORAX DX C+ |
282
|
282
|
|
96413
|
CHEMO IV INFUSION 1 HR |
275
|
275
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
238
|
238
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
234
|
386
|
|
84439
|
ASSAY OF FREE THYROXINE |
222
|
222
|
|
70491
|
CT SOFT TISSUE NECK W/DYE |
192
|
192
|
|
A9552
|
F18 FDG |
171
|
171
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
162
|
238
|
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
151
|
151
|
|
82565
|
ASSAY OF CREATININE |
148
|
149
|
|
78816
|
PET IMAGE W/CT FULL BODY |
144
|
144
|
|
J9299
|
INJECTION, NIVOLUMAB |
144
|
50,752
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C43.30 related to the following DRG Codes:
595-596
|
